Updated Jul 16, 2026
Klinger Shannon Thyme has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $989K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-08 | MRNA | Moderna, Inc. | F — Tax withholding / forfeiture | 5.7K | $51.59 | $294K |
| 2026-06-08 | MRNA | Moderna, Inc. | M — Option exercise | 11.8K | — | |
| 2026-06-08 | MRNA | Moderna, Inc. | S — Open-market sale | 3.5K | $50.00 | $174K |
| 2026-06-08 | MRNA | Moderna, Inc. | M — Option exercise | 3.5K | $30.96 | $107K |
| 2026-06-03 | MRNA | Moderna, Inc. | F — Tax withholding / forfeiture | 1.0K | $47.19 | $49K |
| 2026-06-03 | MRNA | Moderna, Inc. | M — Option exercise | 2.2K | — | |
| 2026-05-29 | MRNA | Moderna, Inc. | F — Tax withholding / forfeiture | 159 | $47.61 | $8K |
| 2026-05-29 | MRNA | Moderna, Inc. | M — Option exercise | 328 | — | |
| 2026-05-29 | MRNA | Moderna, Inc. | F — Tax withholding / forfeiture | 374 | $47.03 | $18K |
| 2026-05-29 | MRNA | Moderna, Inc. | M — Option exercise | 773 | — | |
| 2026-03-06 | MRNA | Moderna, Inc. | F — Tax withholding / forfeiture | 5.7K | $57.80 | $330K |
| 2026-03-06 | MRNA | Moderna, Inc. | M — Option exercise | 11.8K | — | |
| 2026-03-03 | MRNA | Moderna, Inc. | S — Open-market sale [10b5-1] | 13.9K | $52.29 | $726K |
| 2026-03-03 | MRNA | Moderna, Inc. | M — Option exercise [10b5-1] | 13.9K | $30.96 | $430K |
| 2026-03-03 | MRNA | Moderna, Inc. | F — Tax withholding / forfeiture [10b5-1] | 4.2K | $51.71 | $217K |
| 2026-03-03 | MRNA | Moderna, Inc. | M — Option exercise [10b5-1] | 8.7K | — | |
| 2026-03-03 | MRNA | Moderna, Inc. | F — Tax withholding / forfeiture [10b5-1] | 375 | $51.71 | $19K |
| 2026-03-03 | MRNA | Moderna, Inc. | M — Option exercise [10b5-1] | 774 | — | |
| 2026-03-03 | MRNA | Moderna, Inc. | F — Tax withholding / forfeiture [10b5-1] | 160 | $51.71 | $8K |
| 2026-03-03 | MRNA | Moderna, Inc. | M — Option exercise [10b5-1] | 329 | — |
Klinger Shannon Thyme is a corporate insider — currently tracked as Chief Legal Officer of Moderna, Inc. (MRNA). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($989K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Klinger Shannon Thyme profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.